Zydus Lifesciences Ahmedabad oncology injectable plant gets two FDA observations

June 18, 2025
Uncategorized

Zydus clarified that the observations received were minor and unrelated to data integrity. Shares of Zydus Lifesciences Ltd ended at ₹957.80, down by ₹1.10, or 0.11%, on the BSE.

Zydus Lifesciences Ahmedabad oncology injectable plant gets two FDA observations

Leave a ReplyCancel Reply

Bank of India to consider fundraising via long-term infrastructure bonds

BEL bags fresh ₹585-crore defence orders; total tally nears ₹3,500 crore in June

Waaree Renewable’s solar EPC order revised upwards by ₹247 crore to ₹1,480 crore

Fund Flows: FIIs clock third highest single-day buy of 2025 on Friday

US imposes 340.7% countervailing duty on LT Foods arm Ecopure’s organic soybean meal exports